Phosphorex is a leading contract development and manufacturing organization (CDMO) specializing in sustained release formulation, nanomedicine and delivery of nucleic acids.

Since 2005, Phosphorex has been partnering with the biomedical community to develop a variety of microparticles, nanoparticles and particle-based pharmaceutical formulations.

Leveraging our experience and innovative technologies, we encapsulate drugs into microspheres or nanoparticles to enable targeted delivery, protection of therapeutic agents, controlled release and improved bioavailability.

Our integrated solution allows us to support all phases of formulation development, from proof-of-concept to clinical studies.

Pathway
to Clinical

Options for
Engagement

Leadership
and Advisors